Diebold Nixdorf (DBD) Tops Q2 EPS by 14c; updates guidance
Tweet
Share
E-mail
Get Alerts DBD Hot Sheet
Price: $83.16 -0.2%
Financial Fact:
Research, development and engineering expense: 17.6M
Today's EPS Names:
CRMT, More
Financial Fact:
Research, development and engineering expense: 17.6M
Today's EPS Names:
CRMT, More
Join SI Premium – FREE
Diebold Nixdorf (NYSE: DBD) reported Q2 EPS of $1.16, $0.14 better than the analyst estimate of $1.02. Revenue for the quarter came in at $939.7 million versus the consensus estimate of $940.18 million.
GUIDANCE
Full-Year 2024 Financial Outlook
Total Revenue: Flat from previously issued Low single-digit growth guidance
Adjusted EBITDA: $435M - $450M
For earnings history and earnings-related data on Diebold Nixdorf (DBD) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Trump said he was unaware of his earnings from crypto
- JPMorgan Assumes Kanzhun Ltd. (BZ) at Overweight
- RBC Capital Downgrades Bucher Industries AG (BUCN:SW) (BCHHF) to Sector Perform
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
